Cathal Friel, Executive Chairman, Open Orphan discusses their contract with the UK Government
Episode 46, Oct 20, 2020, 12:59 PM
Cathal Friel, Executive Chairman, Open Orphan #ORPH discusses the contract they signed with the UK Government for the Development of a COVID-19 Human Challenge Study Model.
Cathal Friel, Executive Chairman, Open Orphan #ORPH discusses the contract they signed with the UK Government for the Development of a COVID-19 Human Challenge Study Model.
Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Conducted from Europe's only 24-bedroom quarantine clinic with onsite virology providing individually isolated rooms and connected to our specialist laboratory facility.
Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Conducted from Europe's only 24-bedroom quarantine clinic with onsite virology providing individually isolated rooms and connected to our specialist laboratory facility.